Atea Pharmaceuticals (AVIR) Gains from Sales and Divestitures (2020)
Historic Gains from Sales and Divestitures for Atea Pharmaceuticals (AVIR) over the last 1 years, with Q4 2020 value amounting to $20000.0.
- Atea Pharmaceuticals' Gains from Sales and Divestitures changed N/A to $20000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $20000.0, marking a year-over-year change of. This contributed to the annual value of $20000.0 for FY2020, which is N/A changed from last year.
- Per Atea Pharmaceuticals' latest filing, its Gains from Sales and Divestitures stood at $20000.0 for Q4 2020.
- In the past 5 years, Atea Pharmaceuticals' Gains from Sales and Divestitures ranged from a high of $20000.0 in Q4 2020 and a low of $20000.0 during Q4 2020